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The postoperative recurrence rate after colorectal
liver metastases (CLM) resection often exceeds 50%.
1
Chemotherapy has been associated with a signiﬁcant
decrease of CLM recurrence rate.
2 Several prognostic
factors and clinical scores have been reported from
surgical series. These prognostic factors and scores
allow improved patient selection for hepatic resection
and identify high-risk patients for recurrence who
might beneﬁt from adjuvant chemotherapy.
Among the diﬀerent prognostic factors, presence of
hepatic pedicle lymph nodes metastases is now rec-
ognized to be one of the strongest risk factor for tu-
mor relapse and for deleterious eﬀect on survival.
3,4
Interestingly, the survival rate is signiﬁcantly higher
when lymph node involvement is limited to the hep-
atoduodenal ligament and the retropancreatic area
compared to patients with lymph node involvement
along the common hepatic artery and around the
celiac axis. Speciﬁcally, three-year survivors were
observed in patients with hepatoduodenal and ret-
ropancreatic lymph node metastases while no sur-
vival longer than one year was registered for patients
with lymph node metastases around common hepatic
artery and/or celiac axis.
4,5 Finally, several factors
were associated with hepatic pedicle lymph node
metastases including the presence of more than three
liver metastases, liver metastases located in segment 4
and/or 5, presence of a resectable peritoneal deposit,
and poorly differentiated pathological aspect of liver
metastases.
4 Currently, there is no agreement for a
systematic hepatic pedicle lymphadenectomy and/or
lymph node sampling during liver resection for CLM.
Intrahepatic lymphatic invasion has previously
been reported as a pathway of intrahepatic spread in
patients with intrahepatic cholangiocarcinoma
6 and
was associated with a worse outcome. For the ﬁrst
time, Sasaki et al. showed that intrahepatic lymphatic
invasion constitutes a negative prognostic factor after
liver resection for CLM.
7 The article by Korita et al.
published in the Annals of Surgical Oncology inves-
tigated the relationship between intrahepatic lym-
phatic invasion and hepatic lymph node involvement
in CLM.
8 Once again, the authors underlined the
pejorative prognostic value of intrahepatic lymphatic
invasion. They retrospectively analyzed the clinical
and pathological data of 105 consecutive patients
who underwent liver resection for CLM. Specimens
were examined to determine the presence or absence
of intrahepatic lymphatic invasion using a monoclo-
nal antibody (D2-40) for immunohistochemical
staining of intrahepatic lymphatic vessels. They ob-
served a correlation between intrahepatic lymphatic
invasion and hepatic lymph node involvement and
concluded that intrahepatic lymphatic invasion is an
independent prognostic factor for overall and dis-
ease-free survival and for intra- and extrahepatic
recurrence.
Published by Springer Science+Business Media, LLC  2007 The Society of
Surgical Oncology, Inc.
Received August 4, 2007; accepted August 6, 2007; published
online: September 27, 2007.
Address correspondence and reprint requests to: Daniel Jaeck,
MD, PhD, FRCS; E-mail: Daniel.Jaeck@chru-strasbourg.fr
Annals of Surgical Oncology 14(12):3297–3298
DOI: 10.1245/s10434-007-9597-z
3297As pointed out by the authors, their study has
several limitations, mainly due to its retrospective
design, the small sample size, and the absence of a
routine lymphadenectomy. The observed correlation
between intrahepatic lymphatic invasion and hepatic
lymph node involvement seems plausible and statis-
tically signiﬁcant. However, this ﬁnding should be
considered with caution, since lymph nodes dissection
was based on their gross appearance and texture on
palpation at the time of laparotomy. Indeed, the rate
of microscopic hepatic lymph nodes metastases ran-
ged, in several studies, from 11 to 33%.
3–5 Therefore,
removal of only enlarged or palpable lymph nodes
seems insufﬁcient. Selective sampling of the sentinel
lymph node or lymphadenectomy based on preoper-
ative imaging particularly on positron emission
tomography scan,
9,10 would be more sensitive than
palpation alone. Moreover, the authors proposed
immunohistochemical staining to detect intrahepatic
lymphatic invasion. However, it would be interesting,
as a ﬁrst step, to compare the sensitivity and the
speciﬁcity of a standard hematoxylin–eosin histolog-
ical examination with those of immunohistochemical
staining before recommending wider use of the latter
technique.
Among the diﬀerent pathways of intrahepatic inva-
sion by CLM (portal venous invasion, hepatic venous
invasion, sinusoidal invasion, bile duct invasion, peri-
neural invasion, stromal invasion) intrahepatic lym-
phatic invasion is clinically relevant as it is associated
with an invariably lethal outcome at three years with
disease recurrence. Therefore, the most interesting
message of the present study is that in the presence of
intrahepatic lymphatic invasion, surgery alone is
insuﬃcient to achieve long-term survival even after a
curative-intent liver resection for CLM. Further stud-
ies are required to determine whether adjuvant che-
motherapy may improve outcome for these patients.
The hypothesis that intrahepatic lymphatic inva-
sion is a precursor of hepatic pedicle lymph node
metastases needs further investigation. In fact, the
reported intrahepatic lymphatic invasion rate of
15.4%
7 seems similar to the incidence of hepatic
pedicle lymph node involvement (3–33%).
4 Further
evidence of a correlation between intrahepatic lym-
phatic invasion and hepatic pedicle lymph node
metastases is given by the present study. Moreover,
the absence of three-year survivors in the case of
intrahepatic lymphatic invasion suggests that such
invasion may correlate more with distal lymph node
metastases (around the common hepatic artery and
the celiac axis) or other extrahepatic occult metasta-
ses. Identiﬁcation of predictive factors associated
with intrahepatic lymphatic invasion is mandatory.
Supposing that intrahepatic lymphatic invasion is an
adverse prognostic factor for tumor recurrence after
hepatectomy for CLM, a prospective study analyzing
the value of adjuvant chemotherapy in such high-risk
patients would seem justiﬁed.
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